Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases

Carcinogenesis

Volumn 23, Issue 5, 2002, Pages 769-776

  Kondo, Seiji ^a   Kubota, Satoshi ^a   Shimo, Tsuyoshi ^a   Nishida, Takashi ^a   Yosimichi, Gen ^a   Eguchi, Takanori ^a   Sugahara, Toshio ^a   Takigawa, Masaharu ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; RECOMBINANT GROWTH FACTOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; STEADY STATE; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; ZYMOGRAPHY;

EID: 0036262188     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.5.769     Document Type: Article

References (56)

1. Angiogenesis in cancer and other diseases
2. Mechanisms of angiogenesis
3. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
4. Tumor angiogenesis and polyamines: Alpha-difluoro-methylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro
5. The modular architecture of a new family of growth regulators related to connective tissue growth factor
6. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10
7. The connective tissue growth factor/cysteine-rich 61/ nephroblastoma overexpressed (CCN) family
8. Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions
9. The CCN family of angiogenic regulators: The integrin connection
10. Physiological roles of connective tissue growth factor (CTGF/Hcs24): Promotion of endochondral ossification, angiogenesis and tissue remodeling
11. Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway
12. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA
13. Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture
14. Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro
15. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro and angiogenesis in vivo
16. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells
17. Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line
18. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis
19. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein
20. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)
21. Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture
22. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
23. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
24. A matrix metalloproteinase expressed on the surface of invasive tumour cells
25. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
26. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
27. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones
28. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
29. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
30. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
31. Involvement of cis-acting repressive element(s) in the 3′-untranslated region of human connective tissue growth factor gene
32. Regulatory mechanism of human connective tissue growth factor (ctgf/hcs24) gene expression in a human chondrocytic cell line, hcs-2/8
33. Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia
34. Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells
35. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene
36. Identification of an RNA element that confers posttranscriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: Similarities to retroviral RNA-protein interactions
37. Suppression of tumor growth through disruption of hypoxia-inducible transcription
38. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alpha v beta 3, promotes endothelial cell survival, and induces angiogenesis in vivo
39. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
40. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
41. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
42. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia
43. 2 tension
44. Hypoxia-induced transcriptional activation of vascular endothelial growth factor is inhibited by serum
45. The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology?
46. The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells
47. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester
48. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity
49. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells
50. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration
51. The angiogenic factors cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts
52. Positive and negative transcriptional elements of the human type IV collagenase gene
53. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium
54. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties
55. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
56. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions